Publications
- Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells2012 | Faculty of Science, Faculty of Physical Education and Sport, First Faculty of Medicine, Second Faculty of Medicine
- Changes associated with lenalidomide treatment in the gene expression profiles of patients with Del(5q)2012 | First Faculty of Medicine
- Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells2012 | First Faculty of Medicine
- Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia2011 | First Faculty of Medicine
- Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia2010 | First Faculty of Medicine
- Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy2010 | First Faculty of Medicine
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study2009 | First Faculty of Medicine
- Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase2008 | First Faculty of Medicine
- Changes in Gene Expression Profiles in Patients with 5q- Syndrome Caused by Lenalidomide TreatmentPublication without faculty affiliation
- Lenalidomide treatment of patients with 5q- syndrome affects genes located in the TNF pathwayPublication without faculty affiliation
Loading network view...